Forbes March 30, 2018
An aging global population, increased awareness of direct to consumer genetic testing and technological advances among others, put the genetics testing market at $10.3 billion by 2024.
Tommi Lehtonen is the CEO of Blueprint Genetics based in Finland and San Francisco. The company, which provides genetic testing, has more than 100 employees and $19 M in equity to date from Finnish, German, Swiss and San Francisco-based venture capital companies.
Artificial intelligence (AI) is one of the leading drivers of the growth of genetic testing. The combination of AI and genomics data has the potential to drive precision medicine and shed light on why our bodies react to different drugs, viruses and environments. Understanding these things could help change the way...
Today's Sponsors
Today's Sponsor